A targeting peptide improves adenovirus-mediated transduction of a glioblastoma cell line

Wang,Dongyang; Li,Wenbo; Zhang,Hang; Mao,Qinwen; Xia,Haibin

doi:10.3892/or.2014.3065

A targeting peptide improves adenovirus-mediated transduction of a glioblastoma cell line

Authors:
- Dongyang Wang
- Wenbo Li
- Hang Zhang
- Qinwen Mao
- Haibin Xia
View Affiliations

Affiliations: Laboratory of Gene Therapy, Department of Biochemistry, College of Life Sciences, Shaanxi Normal University, Xi'an, Shaanxi 710062, P.R. China, Department of Pathology, Northwestern University, Feinberg School of Medicine, Chicago, IL 60611, USA
Published online on: March 6, 2014 https://doi.org/10.3892/or.2014.3065
Pages: 2093-2098

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The progress of the application of adenovirus in cancer gene therapy is hindered by the lack of expression of native adenovirus receptor on a variety of cancer types. Hence, strategies are needed to retarget the adenoviral vector to non-native cellular surface receptors. In the present study, a new peptide SWDIAWPPLKVP, capable of selectively targeting a human glioblastoma cell line A172, was identified by direct biopanning of phage-display peptide libraries. The binding activity of the phage displaying SWDIAWPPLKVP peptide in A172 was more than 10-fold higher than that of the control phage. We then inserted the selected peptide SWDIAWPPLKVP into adenoviral hexon protein, and observed that the modified Ad5 had increased infectivity in A172 cells, compared with that in control cell lines. These findings demonstrated that a peptide acquired through phage display can mediate cell-specific Ad retargeting when inserted into Ad hexon, suggesting an approach for targeting adenoviral infection to specific cancer cells.

View Figures

View References

1	Breyer B, Jiang W, Cheng H, et al: Adenoviral vector-mediated gene transfer for human gene therapy. Curr Gene Ther. 1:149–162. 2001. View Article : Google Scholar : PubMed/NCBI
2	Kim M, Zinn KRB, Barnett G, et al: The therapeutic efficacy of adenoviral vectors for cancer gene therapy is limited by a low level of primary adenovirus receptors on tumour cells. Eur J Cancer. 38:1917–1926. 2002. View Article : Google Scholar : PubMed/NCBI
3	Wickham TJ, Roelvink PW, Brough, et al: Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types. Nat Biotechnol. 14:1570–1573. 1996. View Article : Google Scholar : PubMed/NCBI
4	Krasnykh VN, Mikheeva GV, Douglas JT, et al: Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. J Virol. 70:6839–6846. 1996.PubMed/NCBI
5	Tomko RP, Xu R and Philipson L: HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci USA. 94:3352–3356. 1997. View Article : Google Scholar : PubMed/NCBI
6	Bergelson JM, Cunningham JA, Droguett G, et al: Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science. 275:1320–1323. 1997. View Article : Google Scholar : PubMed/NCBI
7	Bergelson JM, Krithivas A, Celi L, et al: The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses. J Virol. 72:415–419. 1998.PubMed/NCBI
8	Roelvink PW, Lizonova A, Lee JG, et al: The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E and F. J Virol. 72:7909–7915. 1998.PubMed/NCBI
9	Wickham TJ, Matthias P, Cheresh DA, et al: Integrins α_vβ₃ and α_vβ₅ promote adenovirus internalization but not virus attachment. Cell. 73:309–319. 1993.
10	Nemerow GR, Pache L, Reddy V and Stewart PL: Insights into adenovirus host cell interactions from structural studies. Virology. 384:380–388. 2009. View Article : Google Scholar : PubMed/NCBI
11	Eto Y, Gao JQ, Sekiguchi F, et al: PEGylated adenovirus vectors containing RGD peptides on the tip of PEG show high transduction efficiency and antibody evasion ability. J Gene Med. 7:604–612. 2005. View Article : Google Scholar : PubMed/NCBI
12	Wortmann A, Vöhringer S, Engler T, et al: Fully detargeted polyethylene glycol-coated adenovirus vectors are potent genetic vaccines and escape from pre-existing anti-adenovirus antibodies. Mol Ther. 16:154–162. 2008. View Article : Google Scholar : PubMed/NCBI
13	Sakurai F, Mizuguchi H and Hayakawa T: Efficient gene transfer into human CD34⁺ cells by an adenovirus type 35 vector. Gene Ther. 10:1041–1048. 2003. View Article : Google Scholar : PubMed/NCBI
14	Wohlfahrt ME, Beard BC, Lieber A and Kiem HP: A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL leads to enhanced cancer cell killing in human glioblastoma models. Cancer Res. 67:8783–8790. 2007. View Article : Google Scholar
15	Havenga MJ, Lemckert AA, Grimbergen JM, et al: Improved adenovirus vectors for infection of cardiovascular tissues. J Virol. 75:3335–3342. 2001. View Article : Google Scholar : PubMed/NCBI
16	Goossens PH, Havenga MJ, Pieterman E, et al: Infection efficiency of type 5 adenoviral vectors in synovial tissue can be enhanced with a type 16 fiber. Arthritis Rheum. 44:570–577. 2001. View Article : Google Scholar : PubMed/NCBI
17	Xia H, Anderson B, Mao Q and Davidson BL: Recombinant human adenovirus: targeting to the human transferrin receptor improves gene transfer to brain microcapillary endothelium. J Virol. 74:11359–11366. 2000. View Article : Google Scholar : PubMed/NCBI
18	Rittner K, Schreiber V, Erbs P and Lusky M: Targeting of adenovirus vectors carrying a tumor cell-specific peptide: in vitro and in vivo studies. Cancer Gene Ther. 14:509–518. 2007. View Article : Google Scholar : PubMed/NCBI
19	Jullienne B, Vigant F, Muth E, et al: Efficient delivery of angiostatin K1–5 into tumors following insertion of an NGR peptide into adenovirus capsid. Gene Ther. 16:1405–1415. 2009.PubMed/NCBI
20	Liu S, Mao Q, Zhang W, et al: Genetically modified adenoviral vector with the protein transduction domain of Tat improves gene transfer to CAR-deficient cells. Biosci Rep. 29:103–109. 2009. View Article : Google Scholar : PubMed/NCBI
21	Di B, Mao Q, Zhao J, et al: A rapid generation of adenovirus vector with a genetic modification in hexon protein. J Biotechnol. 157:373–378. 2012. View Article : Google Scholar : PubMed/NCBI
22	Giordano RJ, Cardó-Vila M, Lahdenranta J, et al: Biopanning and rapid analysis of selective interactive ligands. Nat Med. 7:1249–1253. 2001. View Article : Google Scholar : PubMed/NCBI
23	Alexander BL, Ali RR, Alton EW, et al: Progress and prospects: gene therapy clinical trials (part 1). Gene Ther. 14:1439–1447. 2007. View Article : Google Scholar : PubMed/NCBI
24	Aiuti A, Bachoud-Lévi AC, Blesch A, et al: Progress and prospects: gene therapy clinical trials (part 2). Gene Ther. 14:1555–1563. 2007. View Article : Google Scholar
25	Volpers C, Thirion C, Biermann V, et al: Antibody-mediated targeting of an adenovirus vector modified to contain a synthetic immunoglobulin g-binding domain in the capsid. J Virol. 77:2093–2104. 2003. View Article : Google Scholar : PubMed/NCBI
26	Haisma HJ, Grill J, Curiel DT, et al: Targeting of adenoviral vectors through a bispecific single-chain antibody. Cancer Gene Ther. 7:901–904. 2000. View Article : Google Scholar : PubMed/NCBI
27	Arap W, Pasqualini R and Ruoslahti E: Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science. 279:377–380. 1998. View Article : Google Scholar : PubMed/NCBI
28	Curnis F, Arrigoni G, Sacchi A, et al: Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells. Cancer Res. 62:867–874. 2002.PubMed/NCBI
29	Pasqualini R, Koivunen E, Kain R, et al: Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer Res. 60:722–727. 2000.PubMed/NCBI
30	Rasmussen UB, Schreiber V, Schultz H, et al: Tumor cell-targeting by phage-displayed peptides. Cancer Gene Ther. 9:606–612. 2002. View Article : Google Scholar : PubMed/NCBI
31	Belousova N, Krendelchtchikova V, Curiel DT and Krasnykh V: Modulation of adenovirus vector tropism via incorporation of polypeptide ligands into the fiber protein. J Virol. 76:8621–8631. 2002. View Article : Google Scholar : PubMed/NCBI
32	Vigne E, Mahfouz I, Dedieu JF, et al: RGD inclusion in the hexon monomer provides adenovirus type 5-based vectors with a fiber knob-independent pathway for infection. J Virol. 73:5156–5161. 1999.PubMed/NCBI